Indo US Bio-Tech postal ballot e-voting starts July 5

2 min read     Updated on 08 Jul 2026, 02:56 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Indo US Bio-Tech Limited has dispatched the postal ballot notice dated July 4, 2026, to shareholders as on the record date of June 26, 2026. The notice seeks approval for the regularization of Mrs. Hemanshi Darsh Soni as a Non-Executive Independent Director and the appointment of M/s. Bhagat & Associates as Statutory Auditors. Remote e-voting is available from July 5, 2026, to August 3, 2026, with results expected on or before August 5, 2026.

powered bylight_fuzz_icon
44631219

*this image is generated using AI for illustrative purposes only.

Indo US Bio-Tech Limited has completed the dispatch of the postal ballot notice dated July 4, 2026, to all members whose names appear in the register of members as on the cut-off date of June 26, 2026. The notice seeks shareholder approval for the regularization of Mrs. Hemanshi Darsh Soni as a Non-Executive Independent Director for a term of five years and the appointment of M/s. Bhagat & Associates, Chartered Accountants, as Statutory Auditors for a period of five years effective from June 16, 2026. The company has also published the notice in the Western Times English and Gujarati editions on July 5, 2026, under Rule 22 of the Companies (Management and Administration) Rules, 2014.

Mrs. Hemanshi Darsh Soni was initially appointed as an Additional Director on April 21, 2026, for a period of five years, pending shareholder ratification. She is not related to any director on the Board and does not hold directorship in any other listed entity. The proposed statutory auditor, M/s. Bhagat & Associates (FRN: 101100W), is a firm of Chartered Accountants registered with the Institute of Chartered Accountants of India.

The company has informed shareholders that voting can be done only by remote e-voting. The remote e-voting period commences on July 5, 2026, at 9:00 a.m. IST and ends on August 3, 2026, at 5:00 p.m. IST. Members whose names are recorded in the depositories as on the cut-off date of June 26, 2026, are entitled to vote. The Postal Ballot Notice, explanatory statement, and e-voting instructions are available on the company website and the e-voting agency website.

M/s. Amrish Gandhi & Associates, Practicing Company Secretary, has been appointed as the scrutinizer to conduct the postal ballot process. The resolutions will be deemed to be passed on August 3, 2026, and the scrutinizer will submit the report and declare the results on or before August 5, 2026.

Calendar of Events

Particulars Dates
Specified date/Cut off for determining members 26 June, 2026 (Friday)
Date of completion of dispatch of Notice by electronic means 04 July, 2026 (Saturday)
Date of publishing Advertisement in Newspaper 06 July, 2026 (Monday)
Date of Commencement of voting by Electronic Mode 05 July, 2026 (Sunday)
End date of voting by Electronic Mode 03 August 2026 (Monday)
Date on which Resolution will be deemed to be passed 03 August 2026 (Monday)
Date of submission of the Report by the Scrutinizer On or before 05 August, 2026 (Wednesday)
Date of declaration of the result On or before 05 August, 2026 (Wednesday)

Historical Stock Returns for Indo Us Bio-Tech

1 Day5 Days1 Month6 Months1 Year5 Years
+0.97%-3.56%-6.51%-22.04%-56.23%-70.39%

What impact will the regularization of Mrs. Hemanshi Darsh Soni as an Independent Director have on the company's governance framework?

How might the appointment of M/s. Bhagat & Associates as Statutory Auditors influence the company's financial transparency and reporting standards?

What strategic initiatives could the company pursue with a stabilized board and auditor tenure over the next five years?

Indo Us Bio-Tech promoter holds 68.29% stake in FY26

1 min read     Updated on 07 Jul 2026, 05:48 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Promoter Jagdishkumar Devjibhai Ajudiya held 1,36,93,643 shares, or 68.29%, in Indo Us Bio-Tech as of March 31, 2026, with no encumbrances reported during FY26 under SEBI (SAST) Regulations.

powered bylight_fuzz_icon
44929103

*this image is generated using AI for illustrative purposes only.

Promoter Jagdishkumar Devjibhai Ajudiya disclosed holding a 68.29% stake in Indo Us Bio-Tech as on March 31, 2026, confirming no encumbrance of shares during the financial year. The disclosure was submitted to the National Stock Exchange of India in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Shareholding Details

The filing details the promoter's shareholding position at the end of FY26. Ajudiya declared holding 1,36,93,643 shares, which constitutes 68.29% of the total paid-up capital of the company. The disclosure explicitly states that no shares were encumbered, directly or indirectly, throughout the financial year ended March 31, 2026.

Particulars Details
Promoter Name Jagdishkumar Devjibhai Ajudiya
Shares Held 1,36,93,643
Percentage Holding 68.29%
Date of Holding March 31, 2026
Encumbrance Status No encumbrance

Regulatory Compliance

The disclosure was made pursuant to Regulation 31(4) of the SEBI (SAST) Regulations, 2011. This regulation requires promoters to submit an annual declaration of their shareholding at the end of each financial year. The letter, dated April 10, 2026, was submitted on behalf of all promoters of Indo Us Bio-Tech Limited.

Historical Stock Returns for Indo Us Bio-Tech

1 Day5 Days1 Month6 Months1 Year5 Years
+0.97%-3.56%-6.51%-22.04%-56.23%-70.39%

Will the promoter consider increasing their stake further given the high current holding?

How might the lack of encumbrance impact the company's ability to secure future financing?

Are there any potential strategic partnerships or acquisitions on the horizon for Indo Us Bio-Tech?

More News on Indo Us Bio-Tech

1 Year Returns:-56.23%